Teva completes $40.5B Actavis deal, agrees to buy Anda for $500M - Philadelphia Business Journal
Teva, Allergan reach $107 million deal with Rhode Island over opioid crisis
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva Revenue Rises on Allergan Deal, But Its Specialty Drugs Saw Pressure - WSJ
Settling a post-buyout hangover, Allergan gives Teva a $700M remedy | Fierce Pharma
Israel's largest company acquisition: Teva buys Allergan Generics for $40.5 billion, new stage in Israeli business? | EIPA
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva investors fret over $41bn generic drugs deal | Financial Times
Allergan steps away from generics with sale to Teva | Business | Chemistry World
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Allergan Generics acquired by Teva in $40.5bn deal — Financier Worldwide
Teva Springs for $40.5B Allergan Generics Acquisition Instead of Mylan Bid - YouTube
Teva-Allergan deal a booster for Indian companies - The Economic Times
Birth Of A Giant: A Timeline Of Teva And Allergan's Generics Business :: Pink Sheet
Teva's New Approach (NYSE:TEVA) | Seeking Alpha
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid | Reuters
Teva Allergan Merger
Teva buys Allergan's generic drug unit for $40.5B
Teva Pharmaceuticals Announces $40.5 Billion Deal For Allergan's Generic Drug Unit
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Teva acquires Allergan's generics operations in $38.8bn deal - PMLiVE
Teva nears deal for Allergan's generic drugs unit: source | Reuters.com
Allergan sells generic drug unit to Israel's Teva for $40.5 billion - Los Angeles Times
Teva, Allergan complete $39 billion generics deal - CDR – Chain Drug Review
Teva drops bid for Mylan, buys Allergan's generics unit | Pittsburgh Post-Gazette
Teva CEO: Allergan acquisition a game changer - Globes
